Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Legal & Judiciary

U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others

Justina Mboho by Justina Mboho
January 5, 2022
in Legal & Judiciary
U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others
Share on FacebookShare on TwitterShare on Linkedin

A United States court of appeal has on Tuesday renewed a lawsuit against AstraZeneca Plc (AZN.L), Pfizer Inc (PFE.N) and other companies over allegations that their contracts with Iraq’s health ministry aided in funding terrorism that led to the death of Americans during the war in Iraq.

The revived lawsuit was instituted for the District of Columbia Circuit by family members of the victims of the attack in Iraq by the Mahdi group.

According to Reuters, Representatives from the five corporate groups AstraZeneca, GE Healthcare USA Holding, Johnson & Johnson Pfizer and Hoffmann-La Roche Inc said in a joint statement that “further proceedings will show the companies are not responsible in any way.”

Read: Omicron: U.S courts suspend in-person trials slated for January

What happened in court

The plaintiffs argued that Jaysh al-Mahdi, a militia group funded by Hezbollah had power over Iraq’s health ministry and 21 U.S and European Medical Equipment and pharmaceutical companies made corrupt payments to obtain medical-supply contracts.

Lawyers for the companies told the court that in 2003, the companies provided the Iraqi government with life saving breast cancer treatments, hemophilia injections, ultrasounds, electrocardiogram machines, and other medical goods following the U.S-led invasion of Iraq.

Read: UK court grants extradition of WikiLeaks founder, Julian Assange, to the US

The lawyer who argued the appeal on behalf of the companies, Kannon Shanmugam had said in September that a ruling against the companies would have a severe chilling effect on the willingness of companies and non-governmental organizations to often conduct essential activities at the government’s request, in troubled regions.

What you should know

  • In 2020 a federal trial judge had dismissed a lawsuit against the companies.
  • Thse companies included: AstraZeneca, GE Healthcare USA Holding, Johnson & Johnson (JNJ.N) Pfizer and Hoffmann-La Roche Inc.
  • In law, upon an application to a superior court, a case that has already been decided can be litigated again where new facts emerged.

Related

Tags: AstraZeneca PlcAZN.LPFE.NPfizer Inc.United State court of appeal

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Hot forex
Cornerstone
Mega Millions
Polaris Bank
Eco Bank
Access Bank
Bankers Committee
First bank


FCMB
Ikeja Electrics




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • The life and times of a bus conductor in Lagos: The job nobody really wants
    • Meet Ochai Agbaji of Nigerian heritage picked in the 2022 NBA Draft to join Cleveland Cavaliers
    • INEC explains conditions for substitution of vice presidential candidates by political parties

    Follow us on social media:

    Recent News

    “Ó Wà óóó!” —  What I learnt being a bus conductor for one day

    The life and times of a bus conductor in Lagos: The job nobody really wants

    June 25, 2022
    Meet Ochai Agbaji of Nigerian heritage picked in the 2022 NBA Draft to join Cleveland Cavaliers

    Meet Ochai Agbaji of Nigerian heritage picked in the 2022 NBA Draft to join Cleveland Cavaliers

    June 25, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com